PT888340E - Derivados de acido 4-(benzo-1,3-dioxolil)pirrolidino-3-carboxilico como antagonistas de endotelina - Google Patents
Derivados de acido 4-(benzo-1,3-dioxolil)pirrolidino-3-carboxilico como antagonistas de endotelinaInfo
- Publication number
- PT888340E PT888340E PT97905897T PT97905897T PT888340E PT 888340 E PT888340 E PT 888340E PT 97905897 T PT97905897 T PT 97905897T PT 97905897 T PT97905897 T PT 97905897T PT 888340 E PT888340 E PT 888340E
- Authority
- PT
- Portugal
- Prior art keywords
- dioxolyl
- pyrrolidine
- benzo
- derivatives
- carboxylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60072496A | 1996-02-13 | 1996-02-13 | |
| US79450597A | 1997-02-04 | 1997-02-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT888340E true PT888340E (pt) | 2002-12-31 |
Family
ID=27083691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97905897T PT888340E (pt) | 1996-02-13 | 1997-02-10 | Derivados de acido 4-(benzo-1,3-dioxolil)pirrolidino-3-carboxilico como antagonistas de endotelina |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0888340B1 (pt) |
| JP (1) | JP2000504727A (pt) |
| CN (1) | CN1079397C (pt) |
| AR (1) | AR005801A1 (pt) |
| AT (1) | ATE220673T1 (pt) |
| AU (1) | AU714597B2 (pt) |
| BR (1) | BR9707394A (pt) |
| CA (1) | CA2245684A1 (pt) |
| CZ (1) | CZ253698A3 (pt) |
| DE (1) | DE69714024T2 (pt) |
| DK (1) | DK0888340T3 (pt) |
| ES (1) | ES2182029T3 (pt) |
| HU (1) | HUP9902316A3 (pt) |
| IL (1) | IL125453A0 (pt) |
| NZ (2) | NZ331124A (pt) |
| PT (1) | PT888340E (pt) |
| WO (1) | WO1997030046A1 (pt) |
| ZA (1) | ZA971184B (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7208517B1 (en) | 1994-08-19 | 2007-04-24 | Abbott Labortories | Endothelin antagonists |
| US6162927A (en) | 1994-08-19 | 2000-12-19 | Abbott Laboratories | Endothelin antagonists |
| US6124341A (en) * | 1996-02-13 | 2000-09-26 | Abbott Laboratories | Endothelin antagonists |
| HUP0002681A3 (en) * | 1997-06-17 | 2001-09-28 | Abbott Lab | Pyrrolidine carboxylic acid derivatives as endothelin antagonists and pharmaceutical compositions containing the same |
| TR200101234T2 (tr) * | 1997-08-04 | 2002-06-21 | Abbott Laboratories | Endotelin antagonistleri. |
| WO2002008185A1 (en) * | 2000-07-19 | 2002-01-31 | F. Hoffmann-La Roche Ag | Pyrrolidine derivatives as metalloprotease inhibitors |
| WO2002017912A1 (en) * | 2000-08-31 | 2002-03-07 | Abbott Laboratories | Endothelin antagonists |
| RU2259825C9 (ru) * | 2001-06-18 | 2006-04-10 | БиоДием Лимитед | Вещества, проявляющие антимикробную, антигрибковую, антипротозойную активности |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2125980C1 (ru) * | 1991-11-05 | 1999-02-10 | Смитклайн Бичам Корпорейшн | Антагонисты эндотелиновых рецепторов, фармкомпозиция, способ их получения, способ подавления эндотелиновых рецепторов |
| WO1994002474A1 (en) * | 1992-07-17 | 1994-02-03 | Smithkline Beecham Corporation | Endothelin receptor antagonists |
| CA2517691A1 (en) * | 1994-08-19 | 1996-02-29 | Abbott Laboratories | Endothelin antagonists |
-
1997
- 1997-02-10 BR BR9707394A patent/BR9707394A/pt not_active Application Discontinuation
- 1997-02-10 IL IL12545397A patent/IL125453A0/xx unknown
- 1997-02-10 CA CA002245684A patent/CA2245684A1/en not_active Abandoned
- 1997-02-10 ES ES97905897T patent/ES2182029T3/es not_active Expired - Lifetime
- 1997-02-10 NZ NZ331124A patent/NZ331124A/xx unknown
- 1997-02-10 DE DE69714024T patent/DE69714024T2/de not_active Expired - Lifetime
- 1997-02-10 AU AU22678/97A patent/AU714597B2/en not_active Ceased
- 1997-02-10 NZ NZ503383A patent/NZ503383A/en unknown
- 1997-02-10 CN CN97193633A patent/CN1079397C/zh not_active Expired - Fee Related
- 1997-02-10 EP EP97905897A patent/EP0888340B1/en not_active Expired - Lifetime
- 1997-02-10 JP JP9529436A patent/JP2000504727A/ja active Pending
- 1997-02-10 DK DK97905897T patent/DK0888340T3/da active
- 1997-02-10 HU HU9902316A patent/HUP9902316A3/hu unknown
- 1997-02-10 WO PCT/US1997/002128 patent/WO1997030046A1/en not_active Application Discontinuation
- 1997-02-10 PT PT97905897T patent/PT888340E/pt unknown
- 1997-02-10 AT AT97905897T patent/ATE220673T1/de not_active IP Right Cessation
- 1997-02-10 CZ CZ982536A patent/CZ253698A3/cs unknown
- 1997-02-12 AR ARP970100554A patent/AR005801A1/es unknown
- 1997-02-12 ZA ZA9701184A patent/ZA971184B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2267897A (en) | 1997-09-02 |
| HUP9902316A3 (en) | 2001-12-28 |
| ES2182029T3 (es) | 2003-03-01 |
| DE69714024T2 (de) | 2003-03-20 |
| AR005801A1 (es) | 1999-07-14 |
| BR9707394A (pt) | 1999-04-06 |
| CN1079397C (zh) | 2002-02-20 |
| NZ331124A (en) | 2000-05-26 |
| CZ253698A3 (cs) | 1999-03-17 |
| AU714597B2 (en) | 2000-01-06 |
| HUP9902316A2 (hu) | 1999-11-29 |
| DE69714024D1 (de) | 2002-08-22 |
| ATE220673T1 (de) | 2002-08-15 |
| NZ503383A (en) | 2002-02-01 |
| CA2245684A1 (en) | 1997-08-21 |
| EP0888340A1 (en) | 1999-01-07 |
| WO1997030046A1 (en) | 1997-08-21 |
| CN1215401A (zh) | 1999-04-28 |
| DK0888340T3 (da) | 2002-11-04 |
| EP0888340B1 (en) | 2002-07-17 |
| IL125453A0 (en) | 1999-03-12 |
| JP2000504727A (ja) | 2000-04-18 |
| ZA971184B (en) | 1997-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE228117T1 (de) | Kristalline form von 4-(5-methyl-3-phenylisoxazol-4-yl)benzolsulfona id | |
| PT1070058E (pt) | Hidroxiamidas de acido (4-aril-sulfonilamino)-tetra-hidropirano-4-carboxilico | |
| PT977733E (pt) | Derivados de acido arilsulfonilamino-hidroxamico | |
| PT1077957E (pt) | Derivados do acido oxi-iminoalcanoico | |
| PT888359E (pt) | Derivados de pirimidin-4-ona como pesticida | |
| BR9707391A (pt) | Pirazolpirimidinas como antagonistas de receptor de crf | |
| BR9700850A (pt) | Derivados de quinazolina substituídos | |
| NO970511D0 (no) | Nye substituerte oksazolidinoner | |
| PT940391E (pt) | Derivados de quinolina como antagonistas do receptor de taquicinina nk3 | |
| AR028252A1 (es) | Derivados de acido carboxilico como antagonistas ip | |
| PT885215E (pt) | Novos derivados de pirrolidina substituidos com benzo-1,3-dioxolilo e benzofuranilo como antagonistas de endotelina | |
| PT975623E (pt) | Compostos indazolamida utilizados como agentes serotoninergicos | |
| PT1155013E (pt) | Compostos heterociclicos de benzenossulfonamida como antagonistas da bradiquinina | |
| PT888340E (pt) | Derivados de acido 4-(benzo-1,3-dioxolil)pirrolidino-3-carboxilico como antagonistas de endotelina | |
| BR9612326A (pt) | N-acila-4-(benzimidazolila-ou resíduos substituídos de imidazopiridinila)-subatituída como antagonistas de taquicinina | |
| NO984738D0 (no) | Nye substituerte [2-(1-piperazinyl)etoksy]metylforbindelser | |
| ATE386501T1 (de) | Formulierungen von wachstumshormonen | |
| FI962639A0 (fi) | Diaryyli-5,6-fuusioituneita heterosyklisiä happoja leukotrieeniantagonisteina | |
| PT937036E (pt) | Derivados substituidos do acido 4-bifenil-4-hidroxibutirico como inibidores de metaloproteases de matriz | |
| PT964863E (pt) | Oxazolidinonas como antagonistas de 5-ht2a | |
| FI972684A (fi) | Piperidiinietikkahappojohdannaisia, joita voidaan käyttää fibrinogeeniantagonisteina | |
| PT915837E (pt) | Derivados de acido glioxilico | |
| BR9911178B1 (pt) | Derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenometil)-cefems, bem como preparação farmacêutica e uso dos mesmos | |
| PT929517E (pt) | Derivados do acido hidroxamico | |
| DE60012953D1 (de) | 3-amino-2-phenylpiperidinderivate als substanz p antagonisten |